CERTICAN

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug CERTICAN contains one active pharmaceutical ingredient (API):

1	Everolimus UNII 9HW64Q8G6G - EVEROLIMUS
	Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers.
	Read more about Everolimus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AH02	Everolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L04AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5737Y, 5738B, 5739C, 5740D, 6459Y, 6460B, 6461C, 8840G, 8841H, 8842J, 9352F, 9582H
BR	Câmara de Regulação do Mercado de Medicamentos	526525103118214, 526525104114212, 526525105110210
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.978-10-04, 25.979-10-04
EE	Ravimiamet	1155901, 1155912, 1155923, 1155934, 1156047, 1156058, 1156069, 1156070, 1156081, 1156092, 1156104, 1156115, 1156126, 1156137, 1156148, 1156159, 1156160, 1156171, 1156182, 1156193, 1156205, 1156216, 1156227, 1156238
ES	Centro de información online de medicamentos de la AEMPS	66001, 66002, 66006, 66007, 66008, 66009
FI	Lääkealan turvallisuus- ja kehittämiskeskus	014853, 014859, 014917
FR	Base de données publique des médicaments	60298932, 60658711, 62507754, 62654074, 63177804, 64299095
GB	Medicines & Healthcare Products Regulatory Agency	296993, 296995
HK	Department of Health Drug Office	54331, 54333, 54334, 54335
HR	Agencija za lijekove i medicinske proizvode	HR-H-592546271, HR-H-809985014
IL	מִשְׂרַד הַבְּרִיאוּת	4840, 4841, 4842
JP	医薬品医療機器総合機構	3999022F1028, 3999022F2024, 3999022F3020
LT	Valstybinė vaistų kontrolės tarnyba	1016726, 1016727, 1016728, 1016729, 1016730, 1016731, 1016732, 1016733, 1016734, 1016735, 1016736, 1016737, 1016738, 1016739, 1016740, 1016741, 1016742, 1016743, 1021787, 1021788, 1021789, 1021790, 1021791, 1021792
MT	Medicines Authority	MA1249/00401, MA1249/00403
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	266M2003
NG	Registered Drug Product Database	A4-4290, A4-4292
Switch country to Nigeria in order to find specific presentations of CERTICAN
NL	Z-Index G-Standaard, PRK	75078, 75086, 75094
NZ	Medicines and Medical Devices Safety Authority	11346, 11347, 11348, 11349, 11350, 11351
PL	Rejestru Produktów Leczniczych	100132260, 100132320, 100132508, 100328571, 100328588, 100328594
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W42568001, W42568002, W42568003, W42568004, W42569001, W42569002, W42569003, W42569004, W42570001, W42570002, W42570003, W42570004, W42572001, W42572002, W42572003, W42572004
SG	Health Sciences Authority	13193P, 13194P, 13195P, 13196P, 13197P, 13198P
TN	Direction de la Pharmacie et du Médicament	10283431H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504011302, 8699504011357, 8699504070002